Differential expression of protease‐activated receptors in monocytes from patients with primary antiphospholipid syndrome

Abstract

These results provide the first demonstration of increased expression of PARs in monocytes from patients with APS. Thus, PAR antagonists might have therapeutic potential as antithrombotic agents in APS.